About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 162 record(s)
Req # A-2022-001652
Correspondence relating to any abbreviated new drug submission (ANDS) filed since December 1, 2022 where the dosage strength is 25 µg or 50 µg desmopressin.Organization: Health Canada
April 2023
Req # A-2022-001653
Correspondence relating to any abbreviated new drug submission (ANDS) filed since December 1, 2022 where the dosage strength is 10 µg desmopressin in intranasal dosage form.Organization: Health Canada
April 2023
Req # A-2023-000012
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-03-24 for the medicinal ingredient Viladozone. The…Organization: Health Canada
April 2023
Req # A-2023-000015
All acknowledgment letters issued by Health Canada confirming receipt of Abbreviated New Drug Submissions (ANDS) for a drug containing Ivacaftor as medicinal ingredient. The initial cover letter indicating the brand name of the reference drug…Organization: Health Canada
April 2023
Req # A-2023-000029
All records conducted by Health Canada between January 2019 and March 2023 regarding the usage of Messenger Ribonucleic Acid (mRNA) vaccines in livestock.Organization: Health Canada
April 2023
Req # A-2022-001427
The details regarding all procedures, claims or legal action that is currently active or pending or any balance that is owed to you by this company. Company: 9202-7507 Québec Inc. (NEQ 1165486250) 31 Clermont Street, Saint-Lin-Laurentides, Quebec,…Organization: Health Canada
March 2023
Req # A-2022-001479
A human Health Risk Assessment for the proposed telecommunications towers at 1388 Ellenor Road, Comox, V9M 4B3 and 3505 Dove Creek Road, Courtenay, V9J 1P3, the Minister of Health's signed Oath of Allegiance to the Monarch and a copy of the…Organization: Health Canada
March 2023
Req # A-2022-001501
Medical device incident reports for the upper and lower orthodontic Hawley retainer. Licences for this Class II medical device include: Licence No. 72154, Licence No. 90476, Licence No. 96400, Licence No. 95644, Licence No. 32725. Request is not…Organization: Health Canada
March 2023
Req # A-2022-001502
Medical device incident reports for the Orthodontic Facebow/Headgear, also known as the Cervical Headgear. Licences for this Class II medical device include: Licence No. 72154, Licence No. 90476, Licence No. 96400, Licence No. 95644, Licence No.…Organization: Health Canada
March 2023
Req # A-2022-001545
On February 23 2023 Health Canada made an announcement regarding an “agreement in principle for a shared plan that will invest $4.81 billion in federal funding over 10 years in Nova Scotia, including $1.01 billion for a new bilateral agreement…Organization: Health Canada
March 2023